CROSS-LINKING AND PROTEOLYSIS IN CA-2+-TREATED LENS HOMOGENATES

被引:9
作者
VELASCO, PT
MURTHY, P
GOLL, DE
LORAND, L
机构
[1] NORTHWESTERN UNIV,DEPT BIOCHEM MOLEC & CELL BIOL,EVANSTON,IL 60208
[2] UNIV ARIZONA,DEPT ANIM SCI & BIOCHEM,TUCSON,AZ 85721
关键词
Calpain; Crosslinking; Lens; Proteolysis; Transglutaminase;
D O I
10.1016/0167-4838(90)90074-P
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It was previously shown (Lorand et al. (1985) Biochemistry 24, 1525) that treatment of lens homogenate with Ca2+ produces two sets of changes which are catalyzed by intrinsic enzymes of the lens and which can be readily seen by alterations in the sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles of proteins. With the aid of differential inhibitors of the two reactions (e.g., dansylcadaverine and leupeptin) it was possible to distinguish the transglutaminase-dependent cross-linking of proteins from the proteolytic degradative phenomena. We have now shown that the proteins which are affected by the two processes can be compartmentalized differentially by centrifuging the lens homogenate after exposure to Ca2+. The dimeric and oligomeric β-crystallin products of transglutaminase-mediated cross-linking are most clearly visible in the soluble supernatant, whereas the proteolytically susceptible proteins - possibly structural in nature, including vimentin - are predominantly present in the pellet. We have found a compound, 2-[3-(diallylamino)propionyl]benzothiophene, which, by virtue of acting as a noncompetitive inhibitor of transglutaminase as well as of calpains I and II, effectively blocked both the cross-linking seen in the supernatant and the proteolysis seen in the pellet fraction, though perhaps with somewhat different sensitivities. © 1990.
引用
收藏
页码:187 / 191
页数:5
相关论文
共 11 条
[1]  
GOLL D E, 1986, Ciencia Biologica Molecular and Cellular Biology, V11, P75
[2]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[3]  
LORAND L, 1985, ANN NY ACAD SCI, V455, P703, DOI 10.1111/j.1749-6632.1985.tb50450.x
[4]   FORMATION OF A 55000-WEIGHT CROSS-LINKED BETA-CRYSTALLIN DIMER IN THE CA-2+-TREATED LENS - A MODEL FOR CATARACT [J].
LORAND, L ;
CONRAD, SM ;
VELASCO, PT .
BIOCHEMISTRY, 1985, 24 (06) :1525-1531
[5]   AMINE SPECIFICITY IN TRANSPEPTIDATION . INHIBITION OF FIBRIN CROSS-LINKING [J].
LORAND, L ;
RULE, NG ;
FURLANET.OR ;
JACOBSEN, A ;
DOWNEY, J ;
ONER, N ;
BRUNERLO.J .
BIOCHEMISTRY, 1968, 7 (03) :1214-&
[6]   INHIBITION OF PROTEIN CROSS-LINKING IN CA2+-ENRICHED HUMAN-ERYTHROCYTES AND ACTIVATED PLATELETS [J].
LORAND, L ;
BARNES, N ;
BRUNERLORAND, JA ;
HAWKINS, M ;
MICHALSKA, M .
BIOCHEMISTRY, 1987, 26 (01) :308-313
[7]   SPECIFICITY OF GUINEA-PIG LIVER TRANSGLUTAMINASE FOR AMINE SUBSTRATES [J].
LORAND, L ;
PARAMESWARAN, KN ;
STENBERG, P ;
TONG, YS ;
VELASCO, PT ;
JONSSON, NA ;
MIKIVER, L ;
MOSES, P .
BIOCHEMISTRY, 1979, 18 (09) :1756-1765
[8]  
LORAND L, 1983, J BIOL CHEM, V258, P5300
[9]  
LORAND L, 1987, INVEST OPHTH VIS SCI, V28, P1218
[10]  
SAMAMA M, 1979, PROG CHEM FIBRINOLYS, V4, P235